Integrating viral hepatitis prevention into public health programs serving people at high risk for infection: Good public health

Public Health Reports

Volumn 122, Issue SUPPL. 2, 2007, Pages 1-5

  Buffington, Joanna ^a   Jones, T Stephen ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b MS G 37 ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS A VACCINE; HEPATITIS B VACCINE;

EDITORIAL; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CANCER; LIVER CIRRHOSIS; LIVER FAILURE; MORTALITY; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; SEXUAL TRANSMISSION; SEXUALLY TRANSMITTED DISEASE; VIRUS HEPATITIS; ARTICLE; DISEASE TRANSMISSION; HOMOSEXUALITY; MALE; PUBLIC HEALTH SERVICE; SUBSTANCE ABUSE; UNITED STATES;

CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); HEPATITIS, VIRAL, HUMAN; HOMOSEXUALITY, MALE; HUMANS; MALE; PUBLIC HEALTH ADMINISTRATION; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES;

EID: 34250314424     PISSN: 00333549     EISSN: 14682877     Source Type: Journal    
DOI: 10.1177/00333549071220s201     Document Type: Editorial

References (50)

1. Centers for Disease Control and Prevention (US), National Center for Infectious Diseases, Viral Hepatitis Surveillance. Disease burden from hepatitis A, B, and C in the United States. 2005 [cited 2006 Nov 24]. Available from: URL: http://www.cdc.gov/ncidod/diseases/hepatitis/resource/dz_burden.htm
2. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006;144:705-14.
3. Edlin BR. Five million Americans infected with the hepatitis C virus: a corrected estimate (abstract #44). 56th Annual Meeting of the American Association for the Study of Liver Diseases; 2005 Nov 11-15; Boston, Massachusetts. In: Hepatology 2005;42(4 Suppl 1):213A.
4. Glynn M, Rhodes P. Estimated HIV prevalence in the United States at the end of 2003. Abstract no. T1-B1101. Proceedings of the National HIV Prevention Conference; 2005 Jun 12-15; Atlanta, Georgia. Abstract 595. Also available from: URL: http://www.aegis.com/conferences/NHIVPC/2005/T1-B1101.pdf [cited 2006 Nov 24].
5. Goldstein ST, Alter MJ, Williams IT, Moyer LA, Judson FN, Mottram K, et al. Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs. J Infect Dis 2002;185:713-9.
6. CDC (US). Hepatitis surveillance report no. 61. Atlanta: Department of Health and Human Services, CDC; 2006 [cited 2006 Nov 24]. Available from: URL: http://www.cdc.gov/ncidod/diseases/hepatitis/resource/PDFs/hep_surveillance_61. pdf
7. CDC (US). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP), part II: immunization of adults. MMWR Recomm Rep 2006;55(RR-16):1-25. Also available from: URL: http://www.cdc.gov/mmwr/PDF/rr/rr5516.pdf [cited 2007 Jan 8].
8. CDC (US). Estimated numbers of cases of HIV/AIDS, by year of diagnosis and selected characteristics, 2001-2005 - 33 states and U.S. dependent areas with confidential name-based HIV infection reporting. HIV/AIDS surveillance report, 2005. Vol. 17. Atlanta: Department of Health and Human Services, CDC; 2006. Also available from: URL: http://www.cdc.gov/hiv/topics/surveillance/ resources/reports/2005report/table1.htm [cited 2007 Jan 15].
9. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep 1998;47(RR-19):1-39. Also available from: URL: http://www.cdc.gov/mmwr/PDF/rr/rr4719.pdf [cited 2006 Nov 24].
10. Des Jarlais DC, Diaz T, Perlis T, Vlahov D, Maslow C, Latka M, et al. Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am J Epidemiol 2003;157:467-71.
11. Des Jarlais DC, Fisher DG, Newman JC, Trubatch BN, Yancovitz M, Paone D, et al. Providing hepatitis B vaccination to injection drug users: referral to health clinics vs. on-site vaccination at a syringe exchange program. Am J Public Health 2001;91:1791-2.
12. Hahn JA, Page-Shafer K, Lum PJ, Bourgois P, Stein E, Evans JL, et al. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J Infect Dis 2002;186:1558-64.
13. Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 2000;20:1-16.
14. Buffington J, Murray PJ, Schlanger K, Shih L, Badsgard T, Hennessy RR, et al. Low prevalence of hepatitis C virus antibody in men who have sex with men who do not inject drugs. Public Health Rep 2007;122(Suppl 2):63-7.
15. Gunn RA, Murray PJ, Ackers ML, Hardison WG, Margolis HS. Screening for chronic hepatitis B and C virus infections in an urban sexually transmitted disease clinic: rationale for integrating services. Sex Transm Dis 2001;28:166-70.
16. Mark KE, Murray PJ, Callahan DB, Gunn RA. Medical care and alcohol use after testing hepatitis C antibody positive at STD clinic and HIV test site screening programs. Public Health Rep 2007;122:37-43.
17. MacKellar DA, Valleroy LA, Secura GM, McFarland W, Shehan D, Ford W, et al. Two decades after vaccine license: hepatitis B immunization and infection among young men who have sex with men. Am J Public Health 2001;91:965-71.
18. Jourden J, Etkind P. Enhancing HIV/AIDS and STD prevention through program integration. Public Health Rep 2004;119:4-11. Also available from: URL: http://www.publichealthreports.org/userfiles/119_1/119004.pdf [cited 2006 Nov 24].
19. Frieden TR, Das-Douglas M, Kellerman SE, Henning KJ. Applying public health principles to the HIV epidemic. N Engl J Med 2005;353:2397-402.
20. National Coalition of State and Territorial AIDS Directors and National Coalition of STD Directors. STD/HIV Prevention integration; 2002 [cited 2006 Dec 8]. Available from: URL: http://www.ncsddc.org/docs/STDHIVIssuePaperFinal.pdf
21. Association of State and Territorial Health Officials. The integration of HIV/AIDS, STD, and TB prevention and control programs; September 1998 [cited 2006 Nov 24]. Available from: URL: http://www.astho.org/pubs/ integration%20of%20prevention%20and%20control%20progs.pdf
22. Hoffman HL, Castro-Donlan CA, Johnson VM, Church DR. The Massachusetts HIV, hepatitis, addiction services integration (HHASI) experience: responding to the comprehensive needs of individuals with co-occurring risks and conditions. Public Health Rep 2004;119:25-31. Also available from: URL: http://www. publichealthreports.org/userfiles/119_1/119025.pdf [cited 2006 Nov 24].
23. Strauss SM, Astone JM, Des Jarlais DC, Hagan H. Integrating hepatitis C services into existing HIV services: the experiences of a sample of U.S. drug treatment units. AIDS Patient Care STDS 2005;19:78-88.
24. Ward JW, Fenton KA. CDC and progress toward integration of HIV, STD, and viral hepatitis prevention. Public Health Rep 2007;122(Suppl 2):99-101.
25. CDC (US). National hepatitis C prevention strategy; 2001 [cited 2006 Nov 24]. Available from: URL: www.cdc.gov/ncidod/diseases/hepatitis/c/plan /strategy.pdf
26. CDC (US). Hepatitis C coordinator web site portal [cited 2007 Jan 5]. Available from: URL: http://www.cdc.gov/ncidod/diseases/hepatitis/resource/ coordinators_portal.htm
27. CDC (US). Hepatitis B vaccination among high-risk adolescents and adults - San Diego, California, 1998-2001. MMWR Morb Mortal Wkly Rep 2002;19;51(28):618-21. Also available from: URL: http://www.cdc.gov/mmwr/ preview/mmwrhtml/mm5128a3.htm [cited 2006 Nov 24].
28. Fenton KA, Shuchat A. Memorandum on adult hepatitis B vaccination; October 10, 2006 [cited 2007 Jan 5]. Available from: URL: http://www.cdc.gov/ nchstp/od/Dear_colleague/docs/317fundforHepB10%208%202006.pdf
29. Rodewald LE, Tan LJ. Balancing the childhood immunization program with the urgent needs for adult hepatitis B immunization. Public Health Rep 2007;122(Suppl 2):52-4.
30. Harris JL, Jones TS, Buffington J. Hepatitis B vaccination in six STD clinics in the United States committed to integrating viral hepatitis prevention services. Public Health Rep 2007;122(Suppl 2):42-7.
31. Zimmerman R, Finley C, Rabins C, McMahon K. Integrating viral hepatitis prevention into STD clinics in Illinois (excluding Chicago), 1999-2005. Public Health Rep 2007;122(Suppl 2):18-23.
32. Subiadur J, Harris JL, Rietmeijer CA. Integrating viral hepatitis prevention services into an urban STD clinic: Denver, Colorado. Public Health Rep 2007;122(Suppl 2):12-7.
33. Herlihy EJ, Klein SJ, Newcomb ML, Blog DS, Birkhead GS. Expansion of adult hepatitis A and B vaccination in STD clinics and other settings in New York State. Public Health Rep 2007;122(Suppl 2):36-41.
34. Baldy LM, Urbas C, Harris JL, Jones TS, Reichert PE. Establishing a viral hepatitis prevention and control program: Florida's experience. Public Health Rep 2007;122(Suppl 2):24-30.
35. Heseltine G, McFarlane J. Texas statewide hepatitis C counseling and testing, 2000-2005. Public Health Rep 2007;122(Suppl 2):6-11.
36. Klein SJ, Wright LN, Birkhead GS, Mojica BA, Klopf LC, Klein LA, et al. Promoting HCV treatment completion for prison inmates: New York State's Hepatitis C Continuity Program. Public Health Rep 2007;122(Suppl 2):83-8.
37. McLaughlin P. Viral hepatitis vaccination in an opioid treatment program: Hartford, Connecticut, 2002-2005. Public Health Rep 2007;122(Suppl 2):48-51.
38. Stopka TJ, Marshall C, Bluthenthal RN, Webb DS, Truax SR. HCV and HIV counseling and testing integration in California: an innovative approach to increase HIV counseling and testing rates. Public Health Rep 2007;122(Suppl 2):68-73.
39. Hennessy RR, Weisfuse IB, Schlanger K. Does integrating viral hepatitis services into a public STD clinic attract injection drug users for care? Public Health Rep 2007;122(Suppl 2):31-5.
40. Honeycutt AA, Harris JL, Khavjou O, Buffington J, Jones TS, Rein DB. The costs and impacts of testing for hepatitis C virus antibody in public STD clinics. Public Health Rep 2007;122(Suppl 2):55-62.
41. Whiticar P, Liberti T. Advancing integration of HIV, STD, and viral hepatitis services: state perspectives. Public Health Rep 2007;122(Suppl 2):91-5.
42. Zevin B. Managing chronic hepatitis C in primary-care settings: more than antiviral therapy. Public Health Rep 2007;122(Suppl 2):78-82.
43. Arora S, Thornton K, Jenkusky SM, Parish B, Scaletti JV. Project ECHO: linking university specialists with rural and prison-based clinicians to improve care for people with chronic hepatitis C in New Mexico. Public Health Rep 2007;122(Suppl 2):74-7.
44. Kresina TF, Hoffman K, Lubran R, Clark HW. Integrating hepatitis services into substance abuse treatment programs: new initiatives from SAMHSA. Public Health Rep 2007;122(Suppl 2):96-8.
45. Hepatitis B vaccination coverage among adults - United States, 2004. MMWR Morb Mortal Wkly Rep 2006;55(18):509-11. Also available from: URL: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5518a3.htm?s_cid=mm5518a3_e [cited 2006 Nov 24].
46. Armstrong GL. Commentary: modeling the epidemiology of hepatitis C and its complications. Int J Epidemiol 2003;32:725-6.
47. Perz JF, Alter MJ. The coming wave of HCV-related liver disease: dilemmas and challenges. J Hepatol 2006;44:441-3.
48. Wasley A, Finelli L, Bell BP, Alter MJ. The knowledge and behavior of HCV-infected persons identified in a national seroprevalence survey, United States, 2001-2004. Abstract [Poster 445]. Proceedings of the 12th International Symposium on Viral Hepatitis and Liver Disease; 2006 Jul 1-5; Paris, France.
49. Health Resources and Services Administration (US). HIV/AIDS Bureau. Education and training: AIDS education and training centers [cited 2006 Oct 20]. Available from: URL: http://hab.hrsa.gov/educating.htm
50. Health Resources and Services Administration (US). Ryan White CARE Act [cited 2006 Oct 20]. Available from: URL: http://hab.hrsa.gov/history.htm